Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07725822) titled 'An Open Label Trial to Evaluate Efficacy and Safety of Roflumilast 0.3% Cream for Chronic Plaque and Nail Psoriasis' on July 21.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Modern Research Associates, PLLC
Condition:
Chronic Plaque Psoriasis
Nail Psoriasis
Intervention:
Drug: Roflumilast 0.3% topical cream...
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: August 2026
Target Sample Size: 15
Countries of Recruitment:
United States
To know more, v...